Diabetes is one of the fastest growing epidemics, affecting more than 400 million people worldwide.i Approximately one in two people with diabetes remain undiagnosed and untreated, which can result in significant health consequences
CHICAGO (PRWEB) October 23, 2018
Diabetes is one of the fastest growing epidemics, affecting more than 400 million people worldwide.i Approximately one in two people with diabetes remain undiagnosed and untreated, which can result in significant health consequences.1
The number of people living with the condition has continued to skyrocket, yet despite many advances, diabetes management is challenging. A key reason: the dreaded and painful, yet essential fingerstick that more than 30 million Americans with diabetes have to endure up to 12 times a day.
Routine fingersticks are critical to diabetes management and have been the standard of glucose testing for decades; however, studies have shown that patients continue to struggle to adhere to recommendations for glucose monitoring.ii,iii,iv,v,vi,vii,viii,ix Reasons include the cost of test strips, the painful fingersticks and simply forgetting to test. However, lack of testing can lead to missing significant glucose fluctuations, which can result in major health consequences.x
The FDA recently approved a revolutionary glucose monitoring system called the FreeStyle Libre 14 day, allowing Americans with diabetes to manage their glucose levels without the use of a fingerstick for up to 14 days.
In honor of World Diabetes Day on November 14, Type 1 diabetes patient Reny Partain and diabetes educator Amy Folker will highlight the benefits of the recent advancements in diabetes management, as well as share both clinical and first-hand experience for those living with the condition.
Suggested Questions for Amy Folker:
- Can you tell us a little bit about diabetes and the burden people living with the condition regularly face?
- Why is it important for people with diabetes to monitor their glucose levels?
- Tell us about the continuous glucose monitor called FreeStyle Libre 14 day that recently received FDA approval.
- What are some of the challenges that come with the current methods of glucose monitoring?
Suggested Questions for Reny Partain:
- How long have you been living with diabetes?
- What are some challenges associated with living with this condition?
- Tell us about what this meant for your caregiver
- What role has technology like FreeStyle Libre 14 day played in your diabetes management?
- Why is it important to see a bigger picture of your glucose patterns rather than rely on one measurement alone?
- What advice would you give to someone who has recently been diagnosed?
- Where can people go for more information?
Satellite Interview Opportunity
Wednesday, November 14, 2018
7:00 AM - 1:00 PM EST
V.P. Pitching Monkeys Media
i International Diabetes Federation. IDF DIABETES ATLAS - 8TH EDITION. http://www.diabetesatlas.org/
ii Peyrot, M, Rubin, RR, Lauritzen, T. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005;22(10):1379-1385.
iii Harris, MI , National Health and Nutrition Examination Survey . Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24(6):979-982.
iv Vincze, G, Barner, JC, Lopez, D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112-125.
v Vincze, G, Barner, JC, Lopez, D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112-125.
vi Simmons, JH, Chen, V, Miller, KM. Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. Diabetes Care. 2013;36(11):3573-3577.
vii Driscoll, KA, Johnson, SB, Hogan, J. Insulin bolusing software: the potential to optimize health outcomes in type 1 diabetes mellitus. J Diabetes Sci Technol. 2013;7(3):646-652.
viii O’Connell, MA, Donath, S, Cameron, FJ. Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes. 2011;12(6):556-559.
ix Wong, JC, Foster, NC, Maahs, DM. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014;37(10):2702-2709.
x Journal of Diabetes Science and Technology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864180/